Oxford Researchers Received Funding to create world’s first ovarian cancer prevention vaccine
On Oct. 4, 2024, researchers from Oxford university announced they had been awarded funding from Cancer Research UK…
Breast and ovarian cancer linked to thousands of gene variants
On Sept. 18, 2024, researchers from the Wellcome Sanger Institute and their collaborators reported that they had identified…
Anixa Biosciences Announced Publication of Peer-Reviewed Journal Article Highlighting Ovarian Cancer Vaccine Technology
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics | Women's Health
World Ovarian Cancer Day was established
On May 8, 2013, was the first World Ovarian Cancer Day. On this day, ovarian cancer organizations from…
Scientists from NCI and FDA reported that patterns of proteins found in patients’ serum may reflect the presence of ovarian cancer
On Feb. 7, 2002, scientists from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA)…
The Prostate, Lung, Colorectal, and Ovarian trial began recruiting 148,000 men and women, ages 55-74
In 1993, the Prostate, Lung, Colorectal, and Ovarian trial was launched The trial was designed to determine whether…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Taxol (paclitaxel) approved by the FDA for the treatment of ovarian cancer that has failed other therapy
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
Bristol-Myers’ PARAPLATIN (carboplatin) was approved for the treatment of recurrent ovarian cancer
On Mar. 3, 1989, the U.S. Food and Drug Administration (FDA) approved Bristol-Myers’ PARAPLATIN (carboplatin) for the treatment…
Biology | Diagnostics | Disease | Life Science History | Non-Profit Research | Oncology | Therapeutics
FDA approved Cisplatin, a platinum-containing anticancer compound
On Dec. 19, 1978, the U.S. Food and Drug Administration approved Cisplatin for use in testicular and ovarian…
The FDA approved cisplatin (Platinol) for use in combination with other drugs in the treatment of metastatic testicular and metastatic ovarian cancer
In 1978, the U.S. Food and Drug Administration (FDA) approved cisplatin (Platinol) for use in combination with other…